Evidence based methods improve compliance in glaucoma patients

Article

Problems with medication persistance and adherence are common among patients with glaucoma and have many possible causes.

"We know glaucoma medications only work if the patients use them, but our efforts to improve poor adherence must recognize that this behavior has no single cause. Understanding the barriers and risk factors for poor adherence and persistence is the first step toward identifying problems and helping patients to improve. Then, we must sustain our interventions with ongoing reinforcement," Dr. Yumori said.

She reviewed the literature on persistence and adherence among glaucoma patients as the basis for providing evidence-based recommendations on methods to improve compliance. Dr. Yumori divided the approaches into four categories: increasing knowledge, providing motivation, improving patient skills, and assuring access/follow-up to medication and eye care.

Dr. Yumori's tips for increasing knowledge are centered on both providing patients with information about their disease and providing ways for optometrists to understand the patients' medication use and existing obstacles. When interacting with patients on these issues, optometrists need to realize that their beliefs and behaviors influence patient adherence. Also, in order to elicit accurate information from their patients, optometrists may need to work to improve their communication skills.

Beginning with the assumption that most patients are non-adherent, optometrists should use open-ended questions formulated with simple language to identify adherence issues. They should also remain nonjudgmental in their reactions to the responses they receive.

"Acknowledge difficulties with adherence and compliment success," she said. "Recognize that English proficiency and health literacy are barriers to adherence and use an interpreter as needed."

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD, and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, emphasized that every staff member should play a role in myopia management during his presentation at Optometry's Meeting 2025.
© 2025 MJH Life Sciences

All rights reserved.